Centre justifies regulating supply of anti-fungal drug

The Centre on Thursday told the Madras High Court that the demand for liposomal amphotericin-B (LAmB), a drug used for treating mucormycosis, has exceeded the supply available through domestic production as well as imports and therefore, the government had to regulate the supply to the States to avoid hoarding and inequitable distribution.
Appearing before Chief Justice Sanjib Banerjee and Justice Senthilkumar Ramamoorthy, who had initiated suo motu proceedings to monitor COVID-19 related activities, Additional Solicitor General R. Sankaranarayanan said the Centre was working towards increasing the domestic production besides facilitating the increase in imports and early delivery of import orders.